Giulia Becherucci
Appearances
- DateMay 8, 2023BACKGROUND: Local excision (LE) with transanal endoscopic microsurgery (TEM) is an established alternative to radical resection in select early rectal cancers and high-risk patients…
Presenter
Speakers
Azienda Ospedale Universita PadovaAzienda Ospedale Universita Padova - DateMay 6, 2023Socioeconomic status (SES) has proven significant impact on colorectal cancer (CRC) outcomes. Lower SES has correlated with increased comorbidities, risk of postoperative complications, and inadequate adherence to treatment guidelines…
Presenter
Speakers
Azienda Ospedale Universita PadovaAzienda Ospedale Universita Padova - DateMay 7, 2023INTRODUCTION: Due to its rarity, anal adenocarcinoma (AA) does not have a standardized staging system. The tumor (T) stage of an adenocarcinoma arising from the anal canal could be based on depth of invasion, as for rectal adenocarcinoma, or on size, as in anal squamous cell carcinoma…
Speakers
Azienda Ospedale Universita PadovaAzienda Ospedale Universita PadovaPresenter
- DateMay 6, 2023LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM
Presenter
Speakers
Azienda Ospedale Universita PadovaAzienda Ospedale Universita Padova - DateMay 18, 2024BACKGROUND Stage II colorectal cancer should undergo adjuvant therapy only in the presence of risk factors and vascular, lymphatic, and perineural invasion (VELIPI) are risk factors for recurrence after surgery…
Presenter
Speakers
Azienda Ospedale Universita Padova - DateMay 19, 2024BACKGROUND: Adjuvant therapy after rectal cancer surgery is indicated in T4N0 or any T and nodal metastasis and/or risk factors for recurrences…
Speakers
Azienda Ospedale Universita PadovaPresenter